AAO 2016: INNOVATE

LacriScience Hitting Major Milestones in Development of the LacriPen (OIS@AAO 2016)Подробнее

Ocular Therapeutix’s Sawhney Discusses Regeneron, FDA (OIS@AAO 2016)Подробнее

Sensimed CEO Discloses Financing, Next Steps (OIS@AAO 2016)Подробнее

TearScience’s Boorady Touts LipiFlow’s Duration (OIS@AAO 2016)Подробнее

Allegro’s Karageozian (OIS@AAO 2016)Подробнее

Eye Surgeon Walz Discusses Role in Mynosys Pivotal Trial (OIS@AAO 2016)Подробнее

Lurker Says pSivida Has “Tremendous Opportunity” (OIS@AAO 2016)Подробнее

ReVision’s CEO Updates OIS on Raindrop (OIS@AAO 2016)Подробнее

Ophthalmology Pioneer Herbert Recounts Allergan’s Beginnings (OIS@AAO 2016)Подробнее

Novaliq’s Günther Discusses New Role (OIS@AAO 2016)Подробнее

Companies to Watch - Omega Ophthalmics (OIS@AAO 2016)Подробнее

What It Takes to Build an Ophthalmic Franchise (OIS@AAO 2016)Подробнее

Innovative Financing Opportunities: What They’re Looking For (OIS@AAO 2016)Подробнее

Inotek “Transforming Glaucoma Treatments” (OIS@AAO 2016)Подробнее

Aerie’s Anido Praises FDA Consistency (OIS@AAO 2016)Подробнее

QLT: Using Oral Products to Treat Retinal Disorders (OIS@AAO 2016)Подробнее

PowerVision’s Cheskin Delivers 20/20 Update (OIS@AAO 2016)Подробнее

Norris Delivers Updates, Predictions on Private Financings (OIS@AAO 2016)Подробнее

NEI Pursues Innovation on Multiple Tracks (OIS@AAO 2016)Подробнее

How Changes in Physician Payment Can Impact Innovation (OIS@AAO 2016)Подробнее